UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 42,608 Shares of Molina Healthcare, Inc $MOH

Key Points

• UBS Asset Management cut its Molina Healthcare stake by 19.2% in the second quarter, selling 42,608 shares and retaining 179,440 shares valued at approximately $41 million. Institutional investors collectively own 98.5% of the company.
• Molina reported quarterly EPS of $1.51, beating estimates of $1.39, while revenue of $10.87 billion slightly exceeded forecasts. However, revenue declined 4.8% year over year and the company posted a near-zero negative net margin.
• Analyst sentiment remains cautious: the stock has an average “Hold” rating and an average price target of $202.44, roughly in line with its reported opening price of $202.60.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 19.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 179,440 shares of the company's stock after selling 42,608 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.34% of Molina Healthcare worth $41,038,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Baird Financial Group Inc. bought a new stake in Molina Healthcare during the 1st quarter valued at $210,000. NewEdge Advisors LLC grew its position in Molina Healthcare by 33.4% in the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company's stock worth $364,000 after acquiring an additional 277 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company's stock worth $544,000 after purchasing an additional 1,448 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Molina Healthcare by 19.4% during the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company's stock valued at $82,172,000 after acquiring an additional 40,531 shares during the last quarter. Finally, Woodline Partners LP bought a new position in shares of Molina Healthcare during the 1st quarter valued at $1,541,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Stock Performance

NYSE:MOH opened at $202.60 on Friday. The stock has a 50-day simple moving average of $211.38 and a two-hundred day simple moving average of $182.10. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The firm has a market capitalization of $10.58 billion, a PE ratio of -1,125.49, a P/E/G ratio of 29.04 and a beta of 0.75. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $244.89.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating the consensus estimate of $1.39 by $0.12. The firm had revenue of $10.87 billion for the quarter, compared to the consensus estimate of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The company's revenue was down 4.8% on a year-over-year basis. During the same period last year, the firm earned $5.48 EPS. Analysts forecast that Molina Healthcare, Inc will post 5.29 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on MOH. Mizuho set a $215.00 price target on Molina Healthcare in a research note on Monday, June 8th. Zacks Research downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Friday, August 21st. Robert W. Baird raised their price objective on Molina Healthcare from $124.00 to $163.00 and gave the company a "neutral" rating in a research report on Monday, May 11th. Barclays dropped their price target on Molina Healthcare from $184.00 to $180.00 and set an "underweight" rating on the stock in a research report on Friday, July 24th. Finally, Wall Street Zen cut shares of Molina Healthcare from a "hold" rating to a "sell" rating in a research note on Saturday, August 29th. Three analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $202.44.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source